Precisis GmbH
PrivateLast Round
Series B
Jul 24, 2025
Total Funding Raised
$46.84M
Company Overview
Precisis GmbH is a medical technology company that develops minimally invasive neurostimulation therapies for neurological disorders, including its flagship EASEE® brain pacemaker for drug-resistant focal epilepsy.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Precisis GmbH Comparables
Compare Precisis GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Cadence Neuroscience | 83% | |
| NeuroPace | 77% | |
| LivaNova | 77% |
Precisis GmbH Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Jul 24, 2025 | ||||
| Debt | Jul 24, 2025 | ||||
| Accelerator | Jun 5, 2025 | ||||
| Grant | Oct 5, 2022 | ||||
| VC Round | Oct 14, 2021 |
Key People
Founding team and executive leadership
Precisis GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| MedTech Innovator | Accelerator |
| Bundesministerium für Bildung und Forschung | Series A |
| European Investment Bank Group | Debt |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 8, 2025
Monthly visitors increased 78% MoM.
- Oct 15, 2025
Grew 18% QoQ, from 39 to 46 employees.
Recent news
Latest coverage and updates
- expands_offices_inSep 23, 2026
Precisis continues growing its presence in Europe on Sep 23rd '26
- recognized_asSep 23, 2026
Precisis is selected to receive the EIB Innovation Champion Award at the TechEU Equity Summit in Luxembourg on Sep 23rd '26
- attends_eventSep 23, 2026
Precisis is selected to receive the EIB Innovation Champion Award at the TechEU Equity Summit in Luxembourg on Sep 23rd '26
- is_developingSep 23, 2026
Precisis continues to develop EASEE(R) internationally in Sep '26
Precisis GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Precisis GmbH's valuation, stock price, and market status.
Is Precisis GmbH a public or private company?
Precisis GmbH is a private company.
What is the current stock price of Precisis GmbH?
Precisis GmbH is a private company, so its shares have no public market price. Caplight tracks Precisis GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Precisis GmbH worth (valuation)?
Valuation information for Precisis GmbH is not publicly available.
Can I buy Precisis GmbH stock?
Precisis GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Precisis GmbH's last funding round?
Precisis GmbH's most recent funding round was Series B on July 24, 2025.
Who are the main investors in Precisis GmbH?
Key investors in Precisis GmbH include European Innovation Council Fund, European Investment Bank Group.
Will Precisis GmbH IPO soon?
No public IPO plans have been announced for Precisis GmbH.
How can I track Precisis GmbH secondary market activity?
Caplight tracks bids, offers, and trades in Precisis GmbH's shares on secondary markets.